X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
twice-daily lopinavir/ritonavir (103) 103
humans (94) 94
index medicus (89) 89
hiv infections - drug therapy (87) 87
once-daily atazanavir/ritonavir (74) 74
infectious diseases (73) 73
antiretroviral therapy (52) 52
naive hiv-1-infected patients (50) 50
pharmacology & pharmacy (50) 50
adult (49) 49
female (49) 49
hiv (47) 47
male (46) 46
immunology (34) 34
protease inhibitors (33) 33
viral load (33) 33
anti-hiv agents - therapeutic use (31) 31
atazanavir sulfate (30) 30
ritonavir (30) 30
anti-hiv agents - administration & dosage (29) 29
treatment outcome (29) 29
efficacy (28) 28
hiv infections - virology (28) 28
lopinavir (27) 27
atazanavir (26) 26
cd4 lymphocyte count (26) 26
hiv-infected patients (26) 26
middle aged (26) 26
ritonavir - administration & dosage (26) 26
virology (26) 26
combination (25) 25
hiv-1 - drug effects (25) 25
hiv-1-infected patients (25) 25
anti-hiv agents - adverse effects (23) 23
hiv infection (23) 23
ritonavir - therapeutic use (23) 23
active antiretroviral therapy (22) 22
initial treatment (22) 22
human immunodeficiency virus--hiv (21) 21
protease inhibitor (21) 21
tenofovir (21) 21
antiretroviral drugs (20) 20
drug therapy (20) 20
microbiology (20) 20
safety (20) 20
antiretroviral therapy, highly active - methods (19) 19
clinical trials (19) 19
drug administration schedule (19) 19
drug therapy, combination (19) 19
hiv protease inhibitors - therapeutic use (19) 19
highly active antiretroviral therapy (18) 18
oligopeptides - administration & dosage (18) 18
pyridines - administration & dosage (18) 18
aids/hiv (17) 17
double-blind (17) 17
emtricitabine (17) 17
hiv-1 (16) 16
ritonavir - adverse effects (16) 16
antiviral agents (15) 15
drug resistance, viral (15) 15
hiv protease inhibitors - administration & dosage (15) 15
oligopeptides - adverse effects (15) 15
oligopeptides - therapeutic use (15) 15
pyridines - adverse effects (15) 15
pyridines - therapeutic use (15) 15
acquired immune deficiency syndrome--aids (14) 14
adolescent (14) 14
aids (13) 13
co-formulated elvitegravir (13) 13
drug interactions (13) 13
efavirenz (13) 13
health aspects (13) 13
hiv infections - immunology (13) 13
hiv protease inhibitors - adverse effects (13) 13
management (13) 13
therapy (13) 13
treatment-experienced patients (13) 13
young adult (13) 13
antiretroviral therapy, highly active - adverse effects (12) 12
human-immunodeficiency-virus (12) 12
pharmacokinetics (12) 12
rna (12) 12
tenofovir disoproxil fumarate (12) 12
aged (11) 11
human immunodeficiency virus (11) 11
multiple virological failures (11) 11
proteases (11) 11
research (11) 11
studies (11) 11
hiv-1 infection (10) 10
lamivudine (10) 10
reverse-transcriptase inhibitors (10) 10
rna, viral - blood (10) 10
twice-daily raltegravir (10) 10
analysis (9) 9
antiretroviral therapy, highly active (9) 9
article (9) 9
care and treatment (9) 9
clinical trials as topic (9) 9
cohort studies (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2009, Volume 50, Issue 4, pp. 367 - 374
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 02/2011, Volume 66, Issue 2, pp. 363 - 370
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 06/2015, Volume 69, Issue 2, pp. 206 - 215
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 01/2013, Volume 68, Issue 1, pp. 200 - 205
Journal Article
Journal Article
HIV CLINICAL TRIALS, ISSN 1528-4336, 01/2008, Volume 9, Issue 1, pp. 1 - 10
Journal Article
PLOS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2
Objective: To estimate the lifetime cost utility of two antiretroviral regimens (once-daily atazanavir plus ritonavir [ATV+r] versus twice-daily lopinavir/... 
HEART-DISEASE | ECONOMIC-EVALUATION | NAIVE HIV-1-INFECTED PATIENTS | MULTIDISCIPLINARY SCIENCES | CASTLE | ONCE-DAILY ATAZANAVIR/RITONAVIR | TWICE-DAILY LOPINAVIR/RITONAVIR | QUALITY-OF-LIFE | HEALTH-CARE | IRRITABLE-BOWEL-SYNDROME | TENOFOVIR
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 12/2010, Volume 8, Issue 12, pp. 1345 - 1349
Journal Article
CLINICAL DRUG INVESTIGATION, ISSN 1173-2563, 04/2014, Volume 34, Issue 4, pp. 287 - 296
Antiretroviral drug regimen choice may influence changes in body composition. The objective of this study was to compare changes in body composition between... 
METABOLIC SYNDROME | REGIONAL ADIPOSE-TISSUE | IMMUNODEFICIENCY-VIRUS-INFECTION | NAIVE HIV-1-INFECTED PATIENTS | ONCE-DAILY ATAZANAVIR/RITONAVIR | PHARMACOLOGY & PHARMACY | TWICE-DAILY LOPINAVIR/RITONAVIR | ANTIRETROVIRAL THERAPY | INSULIN SENSITIVITY | BOOSTED ATAZANAVIR | LIPOPROTEIN LEVELS
Journal Article
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, ISSN 0213-005X, 01/2013, Volume 31, Issue 1, pp. 36 - 43
Journal Article
Journal Article
Future Virology, ISSN 1746-0794, 08/2015, Volume 10, Issue 8, pp. 949 - 959
Aim: We examined the literature for the efficacy, safety and tolerability of lopinavir/ritonavir (LPV/r)-based regimens in antiretroviral therapy naive... 
protease inhibitor | lopinavir | ritonavir | meta-analysis | baseline viral load | advanced HIV disease | baseline CD4 | MANAGEMENT | ONCE-DAILY ATAZANAVIR/RITONAVIR | INITIAL TREATMENT | NELFINAVIR | HIV-INFECTION | LOPINAVIR-RITONAVIR | TREATMENT-NAIVE | VIROLOGY | DOUBLE-BLIND | TWICE-DAILY LOPINAVIR/RITONAVIR | CELL COUNT
Journal Article